Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Wellcome Sanger Institute
Headquarters: Hinxton, Cambridge, United Kingdom
Website: http://www.sanger.ac.uk
Year Founded: 1992
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 18, 2024
Discovery & Translation
Making preclinical models more human-like
Ten new mouse and 3D cell models meant to better mimic human organ function or disease
BioCentury | Aug 7, 2024
Management Tracks
Flagship’s Quotient names co-founder Campbell CSO
Plus: Cellectis hires Kilcoyne and more from Helio, Sapphiros, Pharmanovia, the ADA and Outcome Capital
BioCentury | May 6, 2024
Product Development
Tale of two WRN inhibitors: a covalent and a non-covalent molecule enter the clinic
As the first two programs targeting the helicase WRN enter the clinic for MSI+ cancers, they set up a comparison of different inhibitory mechanisms
BioCentury | Jan 6, 2024
Discovery & Translation
Immunotherapy, hold the intestinal inflammation; plus Chugai and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 21, 2023
Emerging Company Profile
Quotient: discovering targets via ultra-sensitive somatic genotyping
Flagship-backed Quotient is using cutting-edge sequencing tech to identify actionable somatic mutations linked to disease states
BioCentury | Apr 25, 2023
Discovery & Translation
Prime and base editing for blood disorders, mutation tracing for NASH target discovery and more
BioCentury’s roundup of translational news
BioCentury | Apr 4, 2023
Deals
April 4 Quick Takes: Scorpion, Pierre Fabre enter deal for pair of EGFRs
Plus: EUA for InflaRx’s antibody for COVID-19 and updates from Adcendo, Mercy, Mosaic, Freeline and Gossamer
BioCentury | May 14, 2022
Discovery & Translation
Human Cell Atlas takes major step toward defining cellular diversity of human tissues
Four Science papers characterize over a million human cells based on space, time and gene expression
BioCentury | May 13, 2022
Discovery & Translation
Aro’s protein-siRNA conjugate for Pompe disease; plus Rheos, Mozart and more
BioCentury’s roundup of translational news
BioCentury | May 30, 2020
Product Development
Sorting out COVID-19 consortia
A side-by-side comparison of who’s doing what among COVID-19 consortia
Items per page:
1 - 10 of 35